Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
BMC Medicine
|
October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
Jason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Fenge Li, Ligang Deng, Kyle R Jackson, et al.
Gastroenterology
|
March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
Akira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
JAMA Oncology
|
April 29, 2016
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
Guo Chen, Jennifer L McQuade, David J Panka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Cell Metabolism
|
April 10, 2018
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Tina Cascone, Jodi A McKenzie, Rina M Mbofung, et al.
The Journal of Investigative Dermatology
|
August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma
Alan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Cell Systems
|
October 1, 2018
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Anil Korkut, Sobia Zaidi, Rupa S Kanchi, et al.
Science Translational Medicine
|
March 3, 2017
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh, Pei-Ling Chen, Alexandre Reuben, et al.
Cancer Discovery
|
December 10, 2015
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
BMC Medicine
|
October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
Jason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Fenge Li, Ligang Deng, Kyle R Jackson, et al.
Gastroenterology
|
March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
Akira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
JAMA Oncology
|
April 29, 2016
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
Guo Chen, Jennifer L McQuade, David J Panka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Cell Metabolism
|
April 10, 2018
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Tina Cascone, Jodi A McKenzie, Rina M Mbofung, et al.
The Journal of Investigative Dermatology
|
August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma
Alan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Cell Systems
|
October 1, 2018
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Anil Korkut, Sobia Zaidi, Rupa S Kanchi, et al.
Science Translational Medicine
|
March 3, 2017
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh, Pei-Ling Chen, Alexandre Reuben, et al.
Cancer Discovery
|
December 10, 2015
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, et al.
Page
of 17